Clinical Trials
26 trialsNCT01758042 2026-03-06
BMT
Massachusetts General Hospital
Phase NA Completed
NCT01351805 2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA Completed
NCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
NCT05737160 2025-05-23
Study of Telitacicept in Generalized Myasthenia Gravis
RemeGen Co., Ltd.
Phase 3 Completed
NCT01086059 2025-01-28
OTIS Humira Pregnancy Registry
University of California, San Diego
Completed
NCT05148806 2024-12-09
MELODY
Imperial College London
Completed
NCT04176211 2024-06-03
The Impact of Myasthenia Gravis in the Real World
Vitaccess Ltd
Completed
NCT06035614 2023-09-13
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
Clarteis
Phase NA Completed
NCT05917184 2023-06-23
ADAPT-teleMG
Yale University
Completed
NCT00001582 2023-03-21
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
National Institutes of Health Clinical Center (CC)
Completed
NCT04805099 2021-03-22
CIAD
Hellenic Cooperative Oncology Group
Completed
NCT03490539 2021-02-03
PROMISE-MG
Duke University
Completed
NCT00340600 2020-11-16
Continuation of Follow-up of DES-Exposed Cohorts
National Institutes of Health Clinical Center (CC)
Completed
NCT03348046 2020-03-04
PASSRRA
Hikma Pharmaceuticals LLC
Completed
NCT03492242 2019-09-26
CHIMeRA
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT03140137 2019-04-22
Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases
University Hospital, Brest
Completed
NCT00481637 2019-04-17
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
Rockefeller University
Completed
NCT00806182 2017-05-23
OMS
National Pediatric Neuroinflammation Organization, Inc.
Completed
NCT01953822 2016-12-26
Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
GlaxoSmithKline
Completed
NCT01498627 2015-04-06
PGRx
GlaxoSmithKline
Completed
NCT01153906 2014-12-02
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
GlaxoSmithKline
Completed
NCT00731536 2013-10-16
Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands
Centocor Ortho Biotech Services, L.L.C.
Completed
NCT01210716 2013-09-23
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
Fenwal, Inc.
Phase 3 Completed
NCT01180868 2012-07-31
The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
Jonsson Comprehensive Cancer Center
Completed
NCT01123590 2010-11-23
Characteristics of Patients With Thymoma in Chulalongkorn Hospital
Chulalongkorn University
Completed
NCT00817752 2010-03-18
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation
National University of Natural Medicine
Phase 1 Completed